Literature DB >> 10948149

Induction of interleukin-4 (IL-4) by legionella pneumophila infection in BALB/c mice and regulation of tumor necrosis factor alpha, IL-6, and IL-1beta.

C Newton1, S McHugh, R Widen, N Nakachi, T Klein, H Friedman.   

Abstract

Infection of BALB/c mice with a sublethal concentration of Legionella pneumophila causes an acute disease that is resolved by innate immune responses. The infection also initiates the development of adaptive Th1 responses that protect the mice from challenge infections. To study the early responses, cytokines induced during the first 24 h after infection were examined. In the serum, interleukin-12 (IL-12) was detectable by 3 h and peaked at 10 h, while gamma interferon was discernible by 5 h and peaked at 8 h. Similar patterns were observed in ex vivo cultures of splenocytes. A transient IL-4 response was also detected by 3 h postinfection in ex vivo cultures. BALB/c IL-4-deficient mice were more susceptible to L. pneumophila infection than were wild-type mice. The infection induced higher serum levels of acute-phase cytokines (tumor necrosis factor alpha [TNF-alpha], IL-1beta, and IL-6), and reducing TNF-alpha levels with antibodies protected the mice from death. Moreover, the addition of IL-4 to L. pneumophila-infected macrophage cultures suppressed the production of these cytokines. Thus, the lack of IL-4 in the deficient mice resulted in unchecked TNF-alpha production, which appeared to cause the mortality. Monocyte chemoattractant protein-1 (MCP-1), a chemokine that is induced by IL-4 during Listeria monocytogenes infection, was detected at between 2 and 30 h after infection. However, MCP-1 did not appear to be induced by IL-4 or to be required for the TNF-alpha regulation by IL-4. The data suggest that the early increase in IL-4 serves to regulate the mobilization of acute phase cytokines and thus controls the potential harmful effects of these cytokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10948149      PMCID: PMC101783          DOI: 10.1128/IAI.68.9.5234-5240.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Authors:  D M Underhill; A Ozinsky; A M Hajjar; A Stevens; C B Wilson; M Bassetti; A Aderem
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

Review 2.  Early host-pathogen interactions in the liver and spleen during systemic murine listeriosis: an overview.

Authors:  J W Conlan
Journal:  Immunobiology       Date:  1999-12       Impact factor: 3.144

3.  Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila.

Authors:  N Bhardwaj; T W Nash; M A Horwitz
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

Review 4.  Role of cytokines in sepsis.

Authors:  C E Hack; L A Aarden; L G Thijs
Journal:  Adv Immunol       Date:  1997       Impact factor: 3.543

5.  Legionnaires' disease--still with us.

Authors:  S M Finegold
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

6.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

7.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

8.  IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.

Authors:  T W Nash; D M Libby; M A Horwitz
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

9.  Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function.

Authors:  D K Blanchard; J Y Djeu; T W Klein; H Friedman; W E Stewart
Journal:  J Leukoc Biol       Date:  1988-05       Impact factor: 4.962

10.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

View more
  12 in total

1.  Legionella lipoprotein activates toll-like receptor 2 and induces cytokine production and expression of costimulatory molecules in peritoneal macrophages.

Authors:  Ho Ki Shim; Jeoung Yeon Kim; Mi Jeong Kim; Hee Sun Sim; Dae Won Park; Jang Wook Sohn; Min Ja Kim
Journal:  Exp Mol Med       Date:  2009-10-31       Impact factor: 8.718

2.  Role of Toll-like receptor 9 in Legionella pneumophila-induced interleukin-12 p40 production in bone marrow-derived dendritic cells and macrophages from permissive and nonpermissive mice.

Authors:  Cathy A Newton; Izabella Perkins; Raymond H Widen; Herman Friedman; Thomas W Klein
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

3.  Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae.

Authors:  Abdul Q Khan; Yi Shen; Zheng-Qi Wu; Thomas A Wynn; Clifford M Snapper
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changes.

Authors:  Guangyu Li; Tao Duan; Xiaoyan Wu; Robert B Tesh; Lynn Soong; Shu-Yuan Xiao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.

Authors:  Catherine A Newton; Ping-Jen Chou; Izabella Perkins; Thomas W Klein
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-16       Impact factor: 4.147

6.  In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model.

Authors:  Florence Ader; Rozenn Le Berre; Rémi Fackeure; Dominique Raze; Franco Dante Menozzi; Nathalie Viget; Karine Faure; Eric Kipnis; Benoît Guery; Sophie Jarraud; Jerome Etienne; Christian Chidiac
Journal:  Intensive Care Med       Date:  2008-03-26       Impact factor: 17.440

7.  Recombinant flagellin-PAL fusion protein of Legionella pneumophila induced cell-mediated and protective immunity against bacteremia in BALB/c mice.

Authors:  Ashraf Mohabati Mobarez; Roya Ahmadrajabi; Nima Khoramabadi; Ali Hatef Salmanian
Journal:  World J Microbiol Biotechnol       Date:  2017-09-08       Impact factor: 3.312

8.  Construction of recombinant Mip-FlaA dominant epitope vaccine against Legionella pneumophila and evaluation of the immunogenicity and protective immunity.

Authors:  Jinlei He; Junrong Zhang; Yanxia He; Fan Huang; Jiao Li; Qiwei Chen; Dali Chen; Jianping Chen
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 9.  Viewing Legionella pneumophila Pathogenesis through an Immunological Lens.

Authors:  Xin Liu; Sunny Shin
Journal:  J Mol Biol       Date:  2019-07-25       Impact factor: 6.151

10.  Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells.

Authors:  Reika Takamatsu; Hiromitsu Teruya; Eriko Takeshima; Chie Ishikawa; Kunihiro Matsumoto; Naofumi Mukaida; Jian-Dong Li; Klaus Heuner; Futoshi Higa; Jiro Fujita; Naoki Mori
Journal:  BMC Microbiol       Date:  2010-01-05       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.